A 35-year-old woman with established SLE (ANA+, anti-dsDNA+, low C3/C4) on hydroxychloroquine and prednisolone 10 mg/day presents with acute-onset severe headache, photophobia, and neck stiffness. CSF analysis shows lymphocytic pleocytosis (120 cells/µL, 90% lymphocytes), elevated protein (85 mg/dL), normal glucose, and negative bacterial/viral cultures. MRI brain is normal. What is the most appropriate next step?

Explanation

## Lupus Meningitis: Diagnosis and Management ### Clinical Presentation and CSF Profile This patient presents with **aseptic meningitis** in the context of active SLE: - Meningeal signs (headache, photophobia, neck stiffness) - **Lymphocytic pleocytosis** with normal glucose (hallmark of viral/autoimmune meningitis, NOT bacterial) - **Negative cultures** rule out infectious meningitis - **Normal MRI** excludes structural lesions - **Active SLE serology** (low complement, anti-dsDNA+) **Key Point:** Lupus meningitis is an uncommon but serious CNS manifestation of SLE, presenting as aseptic meningitis. The diagnosis is **clinical** — supported by CSF lymphocytosis, negative cultures, and active SLE serology. Empiric antibiotics are not indicated once infection is excluded. ### Why High-Dose IV Methylprednisolone? **High-Yield:** CNS lupus (including meningitis, transverse myelitis, and acute confusional state) requires **aggressive immunosuppression** with IV methylprednisolone 1 g daily for 3–5 days, followed by oral prednisolone taper [cite:Harrison 21e Ch 319]. **Clinical Pearl:** The patient is already on prednisolone 10 mg/day, which is insufficient for acute CNS disease. Escalation to IV pulse therapy is necessary to suppress the underlying autoimmune inflammation. ### Differential Diagnosis of Aseptic Meningitis in SLE | Diagnosis | CSF Glucose | CSF Protein | Cultures | Key Feature | Management | |-----------|-------------|-------------|----------|-------------|-------------| | **Lupus meningitis** | Normal | Elevated | Negative | Active SLE serology; lymphocytosis | IV methylprednisolone | | **Bacterial meningitis** | Low (<40% serum) | Very high (>200) | Positive | Acute toxicity; PMN predominance | Antibiotics + dexamethasone | | **Viral meningitis** | Normal | Mildly elevated | Negative (initially) | Self-limited; PCR positive | Supportive care ± acyclovir | | **TB meningitis** | Low | Very high | Positive (AFB) | Chronic course; xanthochromia | Anti-TB therapy | ### Treatment Algorithm for CNS Lupus ```mermaid flowchart TD A[SLE patient with meningeal signs]:::outcome --> B[Perform LP + cultures]:::action B --> C{Cultures positive?}:::decision C -->|Yes| D[Treat as bacterial/TB meningitis]:::action C -->|No| E{CSF glucose normal?}:::decision E -->|No| F[Consider TB, fungal]:::action E -->|Yes| G{Active SLE serology?}:::decision G -->|Yes| H[Lupus meningitis]:::outcome G -->|No| I[Viral meningitis; supportive care]:::action H --> J[IV methylprednisolone 1 g daily × 3-5 days]:::action J --> K[Oral prednisolone taper]:::action K --> L[Consider cyclophosphamide if severe/refractory]:::action L --> M[Monitor CSF and clinical response]:::outcome ``` **Mnemonic:** **ASEPTIC** — **A**utoimmune (SLE) meningitis is **ASEPTIC** (negative cultures, normal glucose), requires **S**teroids (IV pulse), not **E**mpiric **P**ancultured **T**herapy (antibiotics), and **I**s **C**onfirmed by **T**esting (active serology, CSF lymphocytosis). ## Why Not the Other Options? - **Empiric antibiotics (ceftriaxone/vancomycin):** Inappropriate once bacterial meningitis is excluded by negative cultures and normal CSF glucose. Continuing antibiotics in aseptic meningitis delays diagnosis and wastes time. - **Oligoclonal bands and IgG index:** These tests are for demyelinating disease (MS, ADEM) and have no role in diagnosing lupus meningitis. The CSF profile is already consistent with autoimmune meningitis in an SLE patient. - **Acyclovir for HSV:** HSV meningitis typically presents with temporal lobe involvement on MRI and positive HSV PCR. This patient has normal MRI and no PCR data. Acyclovir is not indicated and delays appropriate immunosuppression.